What is BofA Securities's price target for CANO?

BofA Securities's latest stated price target for Cano Health Inc. (CANO) is $1.50, from its action on Dec 13, 2022.

What is BofA Securities's rating on CANO?

BofA Securities rates CANO Underperform, a bearish rating, as of Dec 13, 2022.

When did BofA Securities last change its view on CANO?

On Dec 13, 2022, BofA Securities resumes coverage at Underperform, price target $1.50.

BofA Securities CANO price target and rating history

BofA Securities rates Cano Health Inc. (CANO) Underperform with a $1.50 price target, as of its latest action on Dec 13, 2022. It has published 3 rating actions on CANO since May 2022, including 0 upgrades and 1 downgrade.

Current rating: Underperform
Price target: $1.50
Median target, all firms: Too few
Actions on CANO: 3

BofA Securities price target on CANO

BofA Securities price target on CANO, each point a stated target, May 2022 to December 2022.

Every BofA Securities rating on CANO

Dec 13, 2022
ResumeBofA Securities resumes coverage at Underperform, price target $1.50
Jun 15, 2022
DowngradeBofA Securities downgrades to Neutral from Buy, price target $8 to $6
May 3, 2022
InitiateBofA Securities starts coverage at Buy, price target $8

Questions about BofA Securities and CANO

What is BofA Securities's price target for CANO?: BofA Securities's latest stated price target for Cano Health Inc. (CANO) is $1.50, from its action on Dec 13, 2022.
What is BofA Securities's rating on CANO?: BofA Securities rates CANO Underperform, a bearish rating, as of Dec 13, 2022.
When did BofA Securities last change its view on CANO?: On Dec 13, 2022, BofA Securities resumes coverage at Underperform, price target $1.50.

More CANO rating histories

All BofA Securities ratings CANO news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.